Bedell Frazier Investment Counselling’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$762K Buy
27,153
+758
+3% +$20.2K 0.15% 79
2025
Q4
$657K Sell
26,395
-2,076
-7% -$52.4K 0.13% 85
2025
Q3
$725K Sell
28,471
-1,309
-4% -$32.3K 0.15% 83
2025
Q2
$722K Buy
29,780
+6,970
+31% +$163K 0.18% 71
2025
Q1
$578K Sell
22,810
-471
-2% -$12.3K 0.15% 68
2024
Q4
$618K Buy
+23,281
New +$631K 0.15% 71
2023
Q3
Sell
-14,557
Closed -$534K 92
2023
Q2
$534K Sell
14,557
-4,246
-23% -$165K 0.16% 66
2023
Q1
$767K Sell
18,803
-491
-3% -$21.2K 0.22% 57
2022
Q4
$989K Sell
19,294
-2,365
-11% -$113K 0.26% 60
2022
Q3
$948K Buy
21,659
+4,604
+27% +$224K 0.27% 54
2022
Q2
$894K Buy
17,055
+2,775
+19% +$141K 0.27% 48
2022
Q1
$739K Buy
14,280
+1,385
+11% +$71.9K 0.19% 57
2021
Q4
$761K Buy
12,895
+3,491
+37% +$173K 0.19% 65
2021
Q3
$404K Buy
+9,404
New +$417K 0.11% 69
2018
Q1
Sell
-195,269
Closed -$6.71M 57
2017
Q4
$6.71M Buy
195,269
+4,231
+2% +$144K 2.5% 22
2017
Q3
$6.47M Sell
191,038
-1,001
-0.5% -$32.2K 2.98% 17
2017
Q2
$6.12M Buy
192,039
+1,720
+0.9% +$54.2K 2.23% 24
2017
Q1
$6.18M Buy
+190,319
New +$6M 2.35% 22

Other funds holding PFE

Bedell Frazier Investment Counselling's PFE Position: Q1 2026 in Review

Bedell Frazier Investment Counselling increased its Pfizer (PFE) stake by 2.9% in Q1 2026, buying an estimated $20.2K and bringing the position to 27,153 shares worth $762K. The position accounts for 0.15% of the portfolio, ranked #79.

Bedell Frazier Investment Counselling first reported a position in PFE in Q1 2017 and has held it in 18 quarters since. The position peaked at $6.71M in Q4 2017. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Bedell Frazier Investment Counselling held 27,153 shares of Pfizer worth $762K as of Q1 2026.
  • Bedell Frazier Investment Counselling bought 758 Pfizer shares in Q1 2026, an estimated $20.2K.
  • Pfizer made up 0.15% of Bedell Frazier Investment Counselling's portfolio in Q1 2026, its #79 holding.
  • Bedell Frazier Investment Counselling first reported a position in Pfizer in Q1 2017 and has held it in 18 quarters since.
  • Bedell Frazier Investment Counselling's Pfizer position peaked at $6.71M in Q4 2017.
  • 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Bedell Frazier Investment Counselling's 13F filing for Q1 2026, filed 15 May 2026.